DK1414421T3 - Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet - Google Patents

Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet

Info

Publication number
DK1414421T3
DK1414421T3 DK02749123T DK02749123T DK1414421T3 DK 1414421 T3 DK1414421 T3 DK 1414421T3 DK 02749123 T DK02749123 T DK 02749123T DK 02749123 T DK02749123 T DK 02749123T DK 1414421 T3 DK1414421 T3 DK 1414421T3
Authority
DK
Denmark
Prior art keywords
lipodystrophy
renin
inhibitors
treatment
angiotensin system
Prior art date
Application number
DK02749123T
Other languages
English (en)
Inventor
John Francis Martin
Jorge Erusalimsky
Hugh Edward Montgomery
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Application granted granted Critical
Publication of DK1414421T3 publication Critical patent/DK1414421T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK02749123T 2001-08-09 2002-08-07 Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet DK1414421T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119460.4A GB0119460D0 (en) 2001-08-09 2001-08-09 The use of inhibitors of the renin-angiotensin system
PCT/GB2002/003639 WO2003013486A1 (en) 2001-08-09 2002-08-07 The treatment of lipodystrophy

Publications (1)

Publication Number Publication Date
DK1414421T3 true DK1414421T3 (da) 2008-12-08

Family

ID=9920113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02749123T DK1414421T3 (da) 2001-08-09 2002-08-07 Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet

Country Status (19)

Country Link
US (1) US7022693B2 (da)
EP (1) EP1414421B1 (da)
JP (1) JP2005527462A (da)
KR (1) KR20040054665A (da)
CN (1) CN1541094A (da)
AP (1) AP1731A (da)
AT (1) ATE411012T1 (da)
AU (1) AU2002319535B2 (da)
CA (1) CA2456549A1 (da)
DE (1) DE60229398D1 (da)
DK (1) DK1414421T3 (da)
ES (1) ES2332884T3 (da)
GB (1) GB0119460D0 (da)
HU (1) HUP0401041A3 (da)
MX (1) MXPA04001174A (da)
NO (1) NO20040561L (da)
PL (1) PL367941A1 (da)
WO (1) WO2003013486A1 (da)
ZA (1) ZA200400887B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100028439A1 (en) * 2005-05-23 2010-02-04 Elan Pharma International Limited Nanoparticulate stabilized anti-hypertensive compositions
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0635263A3 (en) 1993-06-28 1995-09-27 American Cyanamid Co Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue.
JP5187991B2 (ja) 1997-10-17 2013-04-24 アーク・セラピューティックス・リミテッド レニン−アンジオテンシン系の阻害剤の使用
US7045532B2 (en) * 1999-04-30 2006-05-16 Millennium Pharmaceuticals, Inc. ACE-2 modulating compounds and methods of use thereof
WO2001015674A2 (en) * 1999-08-30 2001-03-08 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US20020013334A1 (en) 2000-06-15 2002-01-31 Robl Jeffrey A. HMG-CoA reductase inhibitors and method

Also Published As

Publication number Publication date
AP2004002980A0 (en) 2004-03-31
CA2456549A1 (en) 2003-02-20
KR20040054665A (ko) 2004-06-25
MXPA04001174A (es) 2005-02-17
WO2003013486A1 (en) 2003-02-20
CN1541094A (zh) 2004-10-27
GB0119460D0 (en) 2001-10-03
ZA200400887B (en) 2005-02-03
AP1731A (en) 2007-03-30
EP1414421A1 (en) 2004-05-06
US20040209941A1 (en) 2004-10-21
ES2332884T3 (es) 2010-02-15
HUP0401041A2 (hu) 2004-08-30
ATE411012T1 (de) 2008-10-15
HUP0401041A3 (en) 2004-10-28
EP1414421B1 (en) 2008-10-15
AU2002319535B2 (en) 2005-01-06
NO20040561L (no) 2004-03-23
JP2005527462A (ja) 2005-09-15
US7022693B2 (en) 2006-04-04
PL367941A1 (en) 2005-03-07
DE60229398D1 (de) 2008-11-27

Similar Documents

Publication Publication Date Title
DK1073658T3 (da) Pyrazolopyrimidinon-cGMP PDE5-inhibitorer til behandling af sexualforstyrrelse
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
FI20060154A (fi) Neurogeneratiivisten tilojen hoito
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1353694T3 (da) Kombinationer af ezetimibe med aspirin til behandling af vaskulære tilstande
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DK1516596T3 (da) Forbedret system til behandling af stress-urinkontinens
DK1345598T3 (da) Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DK3103443T3 (da) Fremgangsmåde til behandling af primær søvnforstyrrelse
DK1553952T3 (da) Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20040497L (no) Amidinderivater for behandling av amyloidose
DK1414421T3 (da) Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DE50209171D1 (de) Verhinderung von membranverblockung bei der abwasseraufbereitung bei der phosphatierung
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer